| DDS | 4,4'-Diamino-Diphenyl-Sulfone = Dapsone |
|---|---|
| Tabs | tablets |
| USP | United States Pharmacopeial convention = United States Pharmacopeia; 미국 약전 |
| USP DI | United States Pharmacopeial convention Dispensing Information |
| USP | United States Pharmacopeia |
| DDS | Dapsone |
|---|---|
| USP | Ultraspiracle |
| USP | United State Pharmacopeia |
| tablets | Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (12 Dec 1998) |
|---|---|
| tablets, enteric-coated | Tablets coated with material that delays release of the medication until after they leave the stomach. (12 Dec 1998) |
| USP | <abbreviation> United States Pharmacopeia. See: Pharmacopeia. (05 Mar 2000) |
| USP unit | A unit as defined and adopted by the United States Pharmacopeia. (05 Mar 2000) |
| motor dapsone neuropathy | A peripheral neuropathy due to ingestion of 4,4-deaminodiphenylsulphone. (05 Mar 2000) |
| dapsone | <drug> Related to the sulphonamides (diaminodiphenyl sulphone) that is used to treat leprosy (of which the causative agent is Mycobacterium leprae). May act by inhibiting folate synthesis. (18 Nov 1997) |
| dapsone neuropathy | A peripheral neuropathy that develops in patients taking dapsone (4,4-diaminodiphenylsulfone); unusual features include being a pure motor neuropathy, and beginning in the hands, sometimes asymmetrically. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|